Drive Capital Formation for Breakthrough MedTech in Alzheimer’s Brain Imaging

Vistim Labs has developed a category-defining technology: in-clinic routine brain imaging. This way, we can answer the question that matters most: is therapy working ? Our propriatery technique works by converting routine EEGs into high-resolution, PET-like brain images — without radiation and entirely in-office. Our platform enables objective monitoring of amyloid/tau clearance and disease progression, giving neurologists and patients the clarity they’ve never had before.

We seek a fractional CFO with deep experience in early-stage MedTech fundraising to help us scale efficiently and successfully.

This is a high-impact, hands-on role for someone who thrives in the earliest stages of company building. You will partner directly with the founders to shape our financial strategy, prepare for institutional capital, and build the infrastructure needed to support rapid commercial growth.

Why This Role Matters Now

Vistim Labs sits at the intersection of two massive tailwinds: the explosion of new Alzheimer’s therapies and the urgent need for better, more accessible diagnostics/monitoring tools. Clinics are adopting our technology because it solves real problems — affordability, accessibility, and radiation-free imaging. To accelerate this mission and reach more patients, we need world-class capital formation expertise.

Your Role

• Lead capital formation strategy and execution for our current and future fundraising rounds (Seed/Series A range).

• Build and maintain strong relationships with medtech, digital health, and life sciences investors.

What We’re Looking For

• Proven track record raising capital for early-stage medtech, diagnostics, or neurology-related companies (multiple successful rounds preferred).

• Strong existing network in medtech and life sciences venture capital.

You do not need to be a full-time, in-house CFO. We are explicitly seeking a high-caliber fractional partner who can commit 15–25 hours per week initially, with flexibility as we grow.

If you have successfully helped early-stage medtech companies raise meaningful capital, built investor confidence, and established financial excellence in resource-constrained environments, we want to talk.

This is a rare opportunity to join a mission-driven team at the exact moment when our technology can meaningfully improve dementia care — and to help shape the financial future of one of the most exciting neurodiagnostic advances in the last decade.

Interested candidates should reply with a brief note, your relevant fundraising experience, and references/referrals from prior medtech engagements. We review all serious inquiries personally.